| Literature DB >> 34646077 |
Shuta Nagata1, Kaoru Tatematsu1, Hitoki Yamaguchi1, Yuki Inoue1, Keisuke Tanaka2, Hidetaka Tasaki3,4, Koumei Shirasuna1, Hisataka Iwata1.
Abstract
PURPOSE: The present study investigated the effects of docosahexaenoic acid (DHA) on the growth of bovine oocytes.Entities:
Keywords: ATP; DHA; lipid; oocyte growth
Year: 2021 PMID: 34646077 PMCID: PMC8499585 DOI: 10.1002/rmb2.12403
Source DB: PubMed Journal: Reprod Med Biol ISSN: 1445-5781
FIGURE 1Antrum formation of OGCs cultured with or without DHA. OGCs were cultured for 16 d, and the ratio of OGCs forming antrum was examined. A, Rate (%) of antrum formation during the culture period. B, A representative picture of OGCs forming antrum. Arrow indicates antrum cavity
Effect of DHA on growth and nuclear maturation of oocytes and number of granulosa cells
| DHA (µmol/L) | Diameter of oocytes and number of GCs | Oocytes at M Ⅱ stage | |||||||
|---|---|---|---|---|---|---|---|---|---|
| No. OGCs | Trial no. | OGCs with AF | Diameter of oocytes | Number of GCs | Trials no. | No. of OGCs | No. of oocytes | M Ⅱ (%) | |
| 0 | 50 | 5 | 20 | 118.8 ± 0.9a | 52 435 ± 6918 | 4 | 39 | 26 | 12 (46.2) |
| 1 | 50 | 5 | 27 | 122.0 ± 1.0b | 66 323 ± 5923 | 4 | 40 | 28 | 14 (50.0) |
| 10 | 50 | 5 | 17 | 120.0 ± 1.2ab | 63 714 ± 7192 | 4 | 40 | 26 | 9 (34.6) |
Ten oocyte granulosa cells complexes (OGCs) were cultured in medium containing vehicle (ethanol), 1 and 10 μmol/L DHA for 16 d. In the first 5 trials, OGCs forming antrum were selected, and diameter (μm) of in vitro grown oocytes and number of GCs surrounding the oocyte was examined. In the next 4 trials, maturation rate of the oocytes following in vitro maturation was examined. a,b: P < .05.
Effect of DHA treatment on fertilization ability of oocytes grown in vitro
| DHA (µmol/L) | No. of OGCs | Trials no. | No of oocytes | Number of fertilized oocytes (%) | ||
|---|---|---|---|---|---|---|
| Total | Normal | Abnormal | ||||
| 0 | 75 | 5 | 40 | 19 (47.5)a | 16 (40.0) | 3 (7.5) |
| 1 | 75 | 5 | 44 | 33 (75.0)b | 25 (56.8) | 8 (18.2) |
Fifteen oocyte granulosa cell complexes (OGCs) were cultured in medium containing vehicle (ethanol) and 1 μmol/L DHA for 16 d, and the rate of fertilization (total rate of oocytes fertilized, normally fertilized, and abnormal fertilized) was examined. a,b: P < .05.
Effect of DHA in culture medium on acetylation levels of H4K12, amount of lipid, and ATP content in oocytes grown in vitro
| DHA con. (µmol/L) | No. of OGCs | No. of oocytes | Levels of H4K12 acetylation | No. of oocytes | Lipid content per oocyte | No. of oocytes | ATP content per oocyte |
|---|---|---|---|---|---|---|---|
| 0 | 70 | 11 | 1.00 ± 0.05a | 18 | 1.00 ± 0.03a | 8 | 2.27 ± 0.12 |
| 1 | 70 | 11 | 1.17 ± 0.04b | 20 | 0.87 ± 0.04b | 11 | 2.64 ± 0.14 |
Oocyte granulosa cells complexes (OGCs) were cultured in medium containing vehicle (ethanol) and 1 μmol/L DHA for 16 d. A total of 70 OGCs were used, and levels of H4K12 acetylation and amount of lipid and ATP content (pmol) per oocyte grown in vitro were examined. a,b: P < .05.
FIGURE 2A, Lipid content in granulosa cells (GCs) derived from OGCs treated with or without DHA. Fluorescent intensity of Nile red per Hoechst staining of GCs. Average of control (vehicle, trial number 7) was defined as 1.0. B, GCs stained with Nile red were examined using a flow cytometer [Colour figure can be viewed at wileyonlinelibrary.com]
FIGURE 3ATP, MMP, lipid content, and reactive oxygen species (ROS) content in the granulosa cells (GCs) which were cultured with or without DHA in 96‐well plate for 2 and 3 days. A, ATP content (pM) per 10,000 cells and (B) MMP of granulosa cells (GCs). Values of control GCs are defined as 1.0 for each day 2 and 3. C, Lipid content of GCs (GCs). Values of control GCs are defined as 1.0 for each day 2 and 3. D, ROS content, values of control are defined as 1.0. The experiment was repeated 12 times. Bar represents standard error mean. *P < .05
KEGG Pathway enriched by differential expressed genes
| Kegg pathways |
|
|---|---|
| Oxidative phosphorylation | 1.358E‐05 |
| Parkinson's disease | 0.000144 |
| Focal adhesion | 0.002378 |
| Ras signaling pathway | 0.006352 |
| Choline metabolism in cancer | 0.006588 |
| Alzheimer's disease | 0.0182385 |
| Glycerophospholipid metabolism | 0.0213112 |
| Platelet activation | 0.0235876 |
| Insulin resistance | 0.0379412 |
| Proteoglycans in cancer | 0.0382745 |
| mTOR signaling pathway | 0.0425702 |
| ECM‐receptor interaction | 0.0450487 |
| PI3K‐Akt signaling pathway | 0.0470851 |